“…The present study investigated the clinical scope and the quality of studies reporting the use of enzymatic-extracted stromal vascular fraction in clinical application, through the level of evidence of the publications, the methodologies used to perform the research and publish the results, the quality of the information related to the SVF, as well as the results obtained in these studies and the safety of the use of the SVF in these applications. In an era where regenerative medicine and cell therapies have emerged promising therapeutic solutions for various pathologies and regenerative applications, the worldwide medical-scientific community has begun to increasingly exploit the potential of ADSCs and a worldwide dedication to investigating the relationship between the fat, the stromal vascular fraction and its regenerative potential in a wide range of preclinical and clinical studies in an expanding global market [ 4 , [101] , [102] , [103] , [104] , [105] , [106] , [107] , [108] , [109] ]. This can be explained by its greater availability and ease of extraction or its higher cell yield relative to other forms of stem cell extraction [ [9] , [10] , [11] ]; thus, SVF has become the focus of attention, discussion and investigation by both clinical and surgical specialties.…”